The American Health Care Act: Summary of House-Passed Bill to Repeal and Replace Portions of the Affordable Care Act and Next Steps in the Senate

May 10, 2017

Reading Time : 1 min

In the attached summary, Akin Gump examines the key policy changes that result from the AHCA and the bill’s impact on various health industry stakeholders. A key issue with the AHCA is that the impact of the House-passed version on health coverage and the federal budget remains uncertain, as the Congressional Budget Office (CBO) has yet to complete its analysis of the legislation. The Akin Gump team identifies three key categories of the AHCA’s reforms:

  • changes in coverage and affordability in the (nonpublic) individual and small group insurance markets
  • alterations in Medicaid expansion and federal participation
  • repeal of several industry taxes that generate a substantial share of the revenue used to pay for the ACA’s coverage expansion.

With House passage secured, the administration and Senate Republicans are wasting no time beginning what will likely be a tedious and lengthy quest to capture 50 votes in the Senate. The summary lays out some of the key players in health policy in the Senate and issues that they will need to tackle in order to advance AHCA to the finish line.

Click here to read the full overview of the AHCA, including the adopted amendments and substantive polices outlined therein, as well as the available CBO cost estimates.

Share This Insight

Previous Entries

Deal Diary

April 12, 2023

Read More

Deal Diary

2022-12-15

On December 14, 2022, the Securities and Exchange Commission (SEC) adopted amendments regarding Rule 10b5-1 insider trading plans and related disclosures. The amendments aim to strengthen investor protections concerning insider trading and to help shareholders understand when and how insiders are trading in securities for which they may at times have material nonpublic information (MNPI). In light of these amendments, issuers should review and revise, if needed, their insider trading policies and equity grant policies.

Read more.

...

Read More

© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.